With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting the Epigenome of Diffuse Intrinsic Pontine Glioma||The Johns Hopkins University School of Medicine / Sama Ahsan, MD||Young Investigator Grants||2014||Maryland|
|Targeting the ETS Transcription Factor Rearrangement EWS/FLI in Ewing sarcoma||Dana-Farber Cancer Institute / Kimberly Stegmaier, MD||Bridge Grants||2012||Massachusetts|
|Targeting the Function of Ezrin in Rhabdomyosarcoma||The Cleveland Clinic Foundation / Neetu Gupta, PhD & Peter Anderson, MD||Innovation Grants||2016||Ohio|
|Targeting the LIN28 Pathway in ATRT||The Johns Hopkins University School of Medicine / Eric Raabe, MD, PhD||'A' Award Grants||2015||Maryland|
|Targeting the Mechanism of Differentiation Arrest in a Novel Model of Acute Leukemia||Massachusetts General Hospital / David Sykes||Young Investigator Grants||2011||Massachusetts|
|Targeting the Metabolic Drivers of Chemo Resistance in Acute Myeloid Leukemia||Harvard University / Nick van Gastel, PhD||Young Investigator Grants||2018||Massachusetts|
|Targeting the Rac GTPase Pathway to Sabotage RAS Signaling in RAS-mutated Leukemia||Boston Children's Hospital / Sara Canovas Nunes, PhD||Young Investigator Grants||2020||Massachusetts|
|Targeting the Six1/Eya Transcriptional Complex to Inhibit Pediatric Sarcomas||University of Colorado Denver / Heide Ford, Ph.D.||Innovation Grants||2014||Colorado|
|Targeting the Surface-ome of Embryonal Brain Tumors||Institut Curie / Olivier Ayrault, PhD||Crazy 8 Pilots||2019|
|Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia||National Cancer Institute / Christopher Chien, PhD||Young Investigator Grants||2014||Maryland|